AI optics now carry the Veeco story
- Veeco sells high-value process tools used to make advanced chips and optical parts.
- In Q1 2026, Semiconductor was 69% of revenue, making it the main business by far.
- China fell to 13% of Q1 revenue from 42% a year earlier, but the United States and Rest of APAC helped offset it.
- The new upside case is more than $250 million of indium phosphide laser equipment orders tied to AI data centers.
- The Axcelis merger is still pending final China approval, so deal timing remains a key swing factor.
AI optics meet merger risk
Veeco is a small but important supplier of machines used in chip and compound semiconductor manufacturing. The story has shifted toward AI infrastructure. The biggest new driver is indium phosphide lasers, which help move data inside AI data centers through optical links.
The bull case is clear. Veeco has more than $250 million of orders for MOCVD, wet processing, and ion beam deposition tools used to make these lasers. Shipments are expected to start in the second half of 2026 and accelerate in 2027. If that ramp works, it can add a new growth leg on top of advanced packaging, data storage, and EUV mask blank tools.
The bear case is also real. China revenue has dropped hard, the Axcelis deal still needs final China approval, and gross margin must recover after weak mix hurt results. Management is aiming for full-year 2026 gross margin of 41% to 43% and an exit rate near 45%. If the second-half ramp does not show up, earnings could stay under pressure.
Selling hard-to-copy factory tools
Veeco makes and services equipment that customers use inside semiconductor fabs. A fab is a factory that builds chips or chip-like parts. Veeco earns most of its money when it sells a tool, then adds service revenue after the tool is installed.
The company competes in narrow areas where process know-how matters. Laser annealing helps form tiny chip features. Ion beam deposition lays down very precise films. MOCVD grows thin crystal layers for compound semiconductors, including indium phosphide.
The pending all-stock merger with Axcelis is a major strategic step. Both companies have shareholder approval, and management expects a second-half 2026 close if China clears the deal. The goal is a larger equipment company with a served available market of more than $5 billion.
This model can produce strong earnings when orders, factory output, and product mix line up. It can also swing fast. A few large customer decisions, a delayed tool acceptance, or a weaker mix can move revenue and margin in a visible way.
The tools that matter
Laser Annealing Systems
These tools use fast heat pulses to help form transistors in advanced logic chips and high-bandwidth memory DRAM. Veeco also has nanosecond annealing evaluation systems that could turn into future production orders.
Ion Beam Deposition Systems
Veeco is a leader in ion beam deposition for EUV mask blanks, which are used in leading-edge chipmaking. Its SPECTOR tool is now also tied to laser facet coating for indium phosphide lasers used in AI optical networks.
Wet Processing Systems
Wet processing supports advanced packaging, which helps connect AI chips and memory. It is also part of the manufacturing flow for indium phosphide lasers.
MOCVD Systems
MOCVD tools grow thin compound semiconductor layers. Veeco's Lumina platform is seeing demand for indium phosphide epitaxy, a key step in making lasers for optical transceivers.
Data Storage Tools
This business has been cyclical, but management says it is fully booked for 2026 with orders extending into 2027. That helps offset weakness in other areas.
Q1 mix shows the pivot
The segment mix is from Q1 2026 revenue. Semiconductor was dominant, while China exposure fell to 13% of revenue from 42% in the prior-year period.
What could break the setup
China blocks or slows the Axcelis deal
High impact · Medium oddsThe merger still needs final approval from China's State Administration for Market Regulation. A long delay would keep the companies separate and could reduce investor confidence in the strategic plan.
Indium phosphide orders ramp too slowly
High impact · Medium oddsThe more than $250 million order book is the main new growth driver. If customers delay fabs, change tool choices, or buy fewer systems, 2027 growth could disappoint.
Gross margin misses the recovery path
Medium impact · Medium oddsMargins have been hurt by product mix and evaluation tool acceptances. Management guided to 41% to 43% gross margin for 2026 and an exit rate near 45%, so the second half matters a lot.
China revenue stays weak
Medium impact · Medium oddsChina was 27% of 2025 revenue, but only 13% of Q1 2026 revenue. Veeco is counting on Tier 1 customers in the United States and Rest of APAC to offset weaker mature-node China demand.
Evaluation tools do not become production orders
Medium impact · Medium oddsSome future growth depends on customers moving from trial systems to high-volume buys. NSA and IBD300 memory evaluations are important examples.
Capacity build-out strains execution
Medium impact · Low oddsDemand for SPECTOR IBD tools could require a large manufacturing scale-up. That can create supplier delays, quality problems, or lower margins if Veeco expands too fast.
In one breath
What does Veeco Instruments do?
Veeco makes process equipment for semiconductor and compound semiconductor manufacturing. Its tools help form chip features, deposit precise films, process wafers, and make optical components.
Why is Veeco tied to AI data centers?
AI data centers need fast optical links to move large amounts of data. Veeco sells tools used to make indium phosphide lasers, which are part of those optical links.
What is the Axcelis merger risk?
Veeco and Axcelis have shareholder approval for an all-stock merger, but the deal still needs final China regulatory approval. If that approval is delayed or blocked, the expected larger equipment company may not be created on the current timeline.
What should investors watch next?
The main items are China approval for the Axcelis merger, the first revenue from the indium phosphide laser orders, and gross margin improvement in the second half of 2026. New production orders from evaluation tools would also support the 2027 growth case.